Why is "Antibody" trending?

Search Interest Perspective

• Doctors worry about FDA scrutiny of RSV shots to protect babies - NPR
• AstraZeneca’s COPD antibody gets Phase 3 wins in broader-than-expected population - Endpoints News
• Cancer-fighting antibodies may trigger autoimmune brain disorders - News-Medical
• Antibody blood filtering may help some Long Covid patients - DutchNews.nl
• Brain on Fire: The Body Attacks the Mind to Kill Cancer - neurosciencenews.com
• Breakthrough Discovery Targets Virus Infecting 95% of the World’s Population - SciTechDaily
• Paediatricians’ blood used to make new treatments for RSV and colds - New Scientist
• Antibody cocktails based on the occupationally acquired immunity of pediatricians neutralize and confer protection against RSV and hMPV - Science | AAAS
• AI turbocharges antibody hunt for binders with drug-like qualities - Nature
• Converge Bio Strengthens AI-Powered Antibody Partnership With Purple Biotech - TipRanks
• Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody - Pharmaceutical Technology
• Sanofi licenses trispecific antibody from Kali with $180M upfront - FirstWord Pharma
• PSMA and Beyond 2026: Modalities for Targeting the Cell Surface - UroToday
• Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform - Business Wire
• Zoetis boss calls for proactive, not reactive care amid antibody hopes - Vet Times
• A Trial of an Antibody–Oligonucleotide Conjugate - The New England Journal of Medicine
• Peptide conjugates loosen up antibody therapeutics for range of conditions - BioXconomy
• AstraZeneca delivers dream result as phase 3 COPD hits breathe life into class rocked by flops - Fierce Biotech
• How Pharmacists Can Navigate Key Differences and Toxicities of Emerging Bispecific Antibodies in R/R DLBCL - Pharmacy Times
• UK biotech co-founded by Nobel laureate secures $86M for antibody program - Endpoints News
• Immune response to cancer may cause brain disease - Cold Spring Harbor Laboratory
• Enabling automated, high-throughput nanobody discovery - Drug Discovery News
• Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody - PR Newswire
• Mathematical modeling of sequential Dengue–Zika infections: dynamic insights into antibody-dependent enhancement and neutralization effects - Nature
• An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1 - The New England Journal of Medicine
• Innovative antibody therapeutic development in China compared with the USA and Europe - Nature
• Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis - GlobeNewswire
• Monitoring and Managing CRS and Neurologic Toxicities with Bispecific Antibodies - OncLive
• Creative Biolabs Advances Precision Oncology with Integrated Bispecific Antibody Design and Payload Delivery Platforms - 24-7pressrelease.com
• The Emergence of Bispecific Antibodies in Lymphoma - Targeted Oncology
• Structural basis of double-stranded RNA recognition by the J2 monoclonal antibody - Nature
• Atomically accurate de novo design of antibodies with RFdiffusion - Nature
• Microscopic Medicines That Work Inside Human Cells Unlock New Treatments for Alzheimer’s Disease - SciTechDaily
• Earendil raises $787m as lead TL1A antibody starts phase 2 - pharmaphorum
• A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity - Nature
• Potent neutralization of Marburg virus by a vaccine-elicited antibody - Nature
• Predicting the conformational flexibility of antibody and T cell receptor complementarity-determining regions - Nature
• Rights to antibody drug from China’s Keymed change hands in US acquisition - South China Morning Post
• AI can speed antibody design to thwart novel viruses: study - Vanderbilt Health News
• New Antibody Therapy Reawakens Immune System to Fight Pancreatic Cancer - Northwestern University
• More than two to tango: multispecifics at ESMO TAT - BioWorld MedTech
• Reliable repurposing of the antibody interactome inside the cell - Nature
• Mechanisms of Antibody Production May Help Improve Vaccines - Northwestern University
• De novo design of epitope-specific antibodies via a structure-driven computational workflow - Nature
• Long COVID antibodies induce persistent pain-like symptoms in mice - News-Medical
• Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryo-EM - Science | AAAS
• Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity - Nature
• Vanderbilt Health team finds potent antibody that neutralizes two dangerous viruses - Vanderbilt Health News
• Antibody Polyreactivity: A Challenger of Immune Paradigms - Pashov - 2025 - Immunology - Wiley Online Library
• Resolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI - Nature
• Fifty years of monoclonals: the past, present and future of antibody therapeutics - Nature
• Novartis adds to immunology pipeline with $2B deal for Excellergy and its anti-IgE drug - FirstWord Pharma
• Intrabodies unlock new treatments for MND and Alzheimer's - healthcare-in-europe.com
• This new antibody test only takes 10 minutes, no blood draw necessary - University of Pittsburgh
• AI, machine learning to speed antibody therapy development - The University of North Carolina at Chapel Hill
• Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment - Nature
• Pfizer’s trispecific antibody shows promise in treating eczema - BioXconomy
• Novartis pens $2B deal for allergy biotech with potential Xolair successor - Fierce Biotech
• Bioengineered bacteria could lead to therapeutic antibody drugs - Cornell Chronicle
• Folding-mediated secretion of pure bispecific antibodies - Nature
• UMass Chan licenses monoclonal antibody for seasonal prevention of Lyme disease to Tonix Pharmaceuticals - UMass Chan Medical School
• 2025 Archive - Maryland School of Medicine
• B cell imprinting in children impairs antibodies to the haemagglutinin stalk - Nature
• Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [89Zr]ZrCl4 - Journal of Nuclear Medicine
• A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles - Nature
• Absci (NASDAQ: ABSI) highlights ABS-201 trial progress and AI drug platform - stocktitan.net
• Batista Lab Study Reveals How Local Antibody Feedback Regulates B Cell Competition and Promotes Immune Diversity - Ragon Institute
• Precise antibody delivery to the brain via nanobubble-actuated focused ultrasound alleviates depression - PNAS
• Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors - Business Wire
• Human germline-like monoclonal antibody against 5T4 enables potent ADC and CAR-T therapies for solid tumors - Nature
• Large mapping of hereditary differences in the immune system - Karolinska Institutet
• Secondary antibody deficiencies: what’s around the corner? - Frontiers
• Purple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform - TipRanks
• The untapped potential of CD8 cells: how cellular immunity may be the key to an HIV cure - Aidsmap
• Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA - Science | AAAS
• How to make an antibody - Works in Progress Magazine
• Monoclonal antibodies revolutionized biomedical science and health care - Nature
• Investigating the volume and diversity of data needed for generalizable antibody–antigen ΔΔG prediction - Nature
• Antibody discovery for next-generation biologics at Harbour BioMed and Nona Biosciences - Nature
• Most babies with biliary atresia test positive for rotavirus antibodies - Liver Disease News
• Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges - ACS Publications
• Boehringer licenses novel antibody for autoimmune diseases - Boehringer Ingelheim
• High-volume antibody testing platform could accelerate disease research and treatment development - news.illinois.edu
• Bridging the Gap in NSCLC Therapy: The Rise of Antibody-Drug Conjugates - openPR.com
• Engineering antibody–drug conjugates targeting an adhesion GPCR, CD97 - PNAS
• Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae - Nature
• Switchbody, an Antigen-Responsive Enzyme Switch Based on Antibody and Its Working Principle - Wiley
• Reconciling specificity and non-specificity in antibody binding: an energy landscape framework for immunology education - Frontiers
• DNA–drug conjugates enable logic-gated drug delivery amplified by hybridization chain reactions - Nature
• Austin's Hormel Institute: Key antibodies discovered in polio battle - KIMT
• Breadth of influenza A antibody cross-reactivity varies by virus isolation interval and subtype - Nature
• Typhoid Antibody Testing Market Expected to Witness Rapid - openPR.com
• Revisiting the streptococcal M protein: modern perspectives on antibody function, host interactions, and therapeutic targeting - Frontiers
• Antibody star Immutrin raises $86m Series A funding - Business Weekly
• AntiBMPNN: Structure‐Guided Graph Neural Networks for Precision Antibody Engineering - Wiley
• How some autoantibodies contribute to clots: The C4BP link and a path to treatment - Medical Xpress
• AbEpiTope-1.0: Improved antibody target prediction by use of AlphaFold and inverse folding - Science | AAAS
• AI-driven innovation in antibody-drug conjugate design - Frontiers
• 50 Years of Monoclonal Antibody Technology: What’s Next? - Research Horizons
• Singapore claims first use of antibody test to track coronavirus infections - Science | AAAS